Evercore ISI Downgrades Rocket Pharmaceuticals (RCKT) Stock, Slashes PT
On May 30, Evercore ISI downgraded Rocket Pharmaceuticals, Inc.
Posts Tagged ‘NASDAQ:RCKT’
Leerink Partners Downgrades Rocket Pharmaceuticals (RCKT) to Market Perform on Danon Disease Blow
Rocket Pharmaceuticals, Inc.’s (NASDAQ:RCKT) prospects have taken a significant hit on the company being forced to halt research on its experimental gene therapy for Danon Disease...
William Blair Reaffirms Outperform Rating on Rocket Pharma Despite Trial Setback
Sami Corwin, an analyst at William Blair, maintained his Outperform rating on Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals, Inc. (RCKT) Gene Therapy Trial Paused Following Patient Death
Rocket Pharmaceuticals, Inc.
10 Best Low Priced Biotech Stocks to Buy Now
On May 8, Michael Yee, Senior Biotech Analyst at Jefferies, appeared on CNBC to discuss how tariffs and policy risks are pressuring the biotech industry, while simultaneously ...
10 Stocks Under $10 that Will Triple
As we delve into the discussion on stocks that will triple, we must shed light on the U.S.
10 Best US Stocks Under $10 to Buy Right Now
On March 12, Stephanie Guild of Robinhood and Marci McGregor of Bank of America Merrill Lynch shared their perspectives on the current state of the market and strategies for navigating...
Rocket Pharmaceuticals, Inc. (RCKT): A Bull Case Theory
We came across a bullish thesis on Rocket Pharmaceuticals, Inc. (RCKT) on Twitter by sharkbiotech. In this article, we will summarize the bulls’ thesis on RCKT.
10 Best Gene Therapy Stocks to Buy Right Now
Gene therapy is referred to as a medical technique that involves modifying or manipulating genes to treat or prevent disease.
Should You Maintain Your Conviction in Rocket Pharmaceuticals (RCKT)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Should You Retain Your Conviction in Rocket Pharmaceuticals (RCKT)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.
15 Best Strong Buy Stocks To Invest In
In this piece, we will take a look at the 15 best strong buy stocks to invest in.
Should You Maintain Your Conviction in Rocket Pharmaceuticals (RCKT)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
11 Most Promising Biotech Stocks to Buy According to Analysts
In this article, we will take a look at the 11 most promising biotech stocks to buy according to analysts.
Billionaire Lee Ainslie’s Top 10 Stock Picks
Hedge fund managers are known for investing in various asset classes in the race to unlock value in the market.
Should You Hold Rocket Pharmaceuticals (RCKT)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.
10 Oversold Biotech Stocks to Buy
In this article, we will take a look at the 10 oversold biotech stocks to buy.
12 Stocks with Biggest Upside Potential According to Analysts
In this article, we will take a look at the 12 stocks with biggest upside potential according to analysts.
Here’s Why Rocket Pharmaceuticals (RCKT) Stock Suffered in Q1
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
What Makes Rocket Pharmaceuticals (RCKT) Shares Attractive?
Baron Funds, an investment management company, released its “Baron Opportunity Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here.
12 Cash-Rich Small Cap Stocks To Invest In
In 2022, standard diversified portfolios suffered through their worst-performing year in a century.
15 Small Company Stocks You Should Own Now for the Next Decade
In this article, we discuss 15 small company stocks you should own now for the next decade.
Hedge Fund and Insider Trading News: Leon Cooperman, Graticule Asset Management, Blackwells Capital, AQR Capital Management, Maverick Capital, Bridgewater Associates, Rocket Pharmaceuticals Inc (RCKT), and More
From Citizen Kane, chairman of the board Bernstein quips, “it’s no trick to make a lot of money… if what you want to do is make a lot of money.” Downright laughable was...
10 Healthcare Stocks to Buy According to Lee Ainslie’s Maverick Capital
In this piece, we will take a look at the ten healthcare stocks to buy according to Lee Ainslie's Maverick Capital.
Hedge Funds Are Selling Rocket Pharmaceuticals, Inc. (RCKT)
In this article we are going to use hedge fund sentiment as a tool and determine whether Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) is a good investment right now.
10 Pharmaceutical Stocks to Buy Today According to Tiger Cub Billionaire Lee Ainslie
In this article, we will take a look at 10 pharmaceutical stocks to buy today according to Tiger Cub Billionaire Lee Ainslie.
Should I Avoid Rocket Pharmaceuticals, Inc. (RCKT)?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market...
Is RCKT Stock A Buy or Sell?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Is RCKT A Good Stock To Buy Now?
After several tireless days we have finished crunching the numbers from nearly 817 13F filings issued by the elite hedge funds and other investment firms that we track at Insider...
Here is What Hedge Funds Think About Rocket Pharmaceuticals, Inc. (RCKT)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Aren’t Crazy About Rocket Pharmaceuticals, Inc. (RCKT) Anymore
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Was The Smart Money Right About Rocket Pharmaceuticals (RCKT)?
Will the new coronavirus cause a recession in US in the next 6 months? On February 27th, we put the probability at 75% and we predicted that the market will decline by at least...
Did Hedge Funds Drop The Ball On Rocket Pharmaceuticals, Inc. (RCKT) ?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the...
Should You Buy Rocket Pharmaceuticals, Inc. (RCKT)?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th.
Here’s What Hedge Funds Think About Rocket Pharmaceuticals, Inc. (RCKT)
We at Insider Monkey have gone over 738 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio...
Here’s What Hedge Funds Think About Rocket Pharmaceuticals, Inc. (RCKT)
"Market conditions are changing.
Three Biotech Investment Ideas from Cormorant Asset Management
The biotech industry is regaining ground it lost in 2016 at full speed.
13D Filing: Adage Capital Management and Rocket Pharmaceuticals Inc. (RCKT)
Please follow Adage Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Adage Capital Management or update its...
